Literature DB >> 20468068

Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease.

Lorena de Mena1, Eliecer Coto, Lucía F Cardo, Marta Díaz, Marta Blázquez, René Ribacoba, Carlos Salvador, Pau Pastor, Lluis Samaranch, Germán Moris, Manuel Menéndez, Ana I Corao, Victoria Alvarez.   

Abstract

MicroRNAs are small RNA sequences that negatively regulate gene expression by binding to the 3' untranslated regions of mRNAs. MiR-133b has been implicated in Parkinson's disease (PD) by a mechanism that involves the regulation of the transcription factor PITX3. The variation in these genes could contribute to the risk of developing PD. We searched for DNA variants in miR-133 and PITX3 genes in PD patients and healthy controls from Spain. We found common DNA variants in the three miR-133 genes. Genotyping of a first set of patients (n = 777) and controls (n = 650) showed a higher frequency of homozygous for a miR-133b variant (-90 del A) in PD-patients (6/575; 1%) than in healthy controls (0/650) (P = 0.03). However, this association was not confirmed in a second set of patients (1/250; 0.4%) and controls (2/210; 1%). No common PITX3 variants were associated with PD, although a rare missense change (G32S) was found in only one patient and none of the controls. In conclusion, we report the variation in genes of a pathway that has been involved in dopaminergic neuron differentiation and survival. Our work suggests that miR-133 and PITX3 gene variants did not contribute to the risk for PD. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20468068     DOI: 10.1002/ajmg.b.31086

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  22 in total

1.  Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease.

Authors:  Ana Miar; Victoria Alvarez; Ana I Corao; Marta Díaz; Belén Alonso; Carmen Martínez; María T Calatayud; Manuel Menéndez; Germán Morís; Eliecer Coto
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

2.  Neuroprotective Role of MicroRNA-22 in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via Regulation of Its Target Gene TRPM7.

Authors:  Chao Ping Yang; Zhen Hua Zhang; Li Hua Zhang; Han Chen Rui
Journal:  J Mol Neurosci       Date:  2016-09-08       Impact factor: 3.444

Review 3.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

4.  Mutational screening of PARKIN identified a 3' UTR variant (rs62637702) associated with Parkinson's disease.

Authors:  Lorena de Mena; L Luís Samaranch; Eliecer Coto; Lucía F Cardo; René Ribacoba; Oswaldo Lorenzo-Betancor; Pau Pastor; Li Wang; Jaione Irigoyen; Ignacio F Mata; Marta Díaz; Germán Moris; Manuel Menéndez; Ana I Corao; Elena Lorenzo; Victoria Alvarez
Journal:  J Mol Neurosci       Date:  2012-12-30       Impact factor: 3.444

5.  Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice.

Authors:  Mary P Heyer; Amar K Pani; Richard J Smeyne; Paul J Kenny; Guoping Feng
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

6.  Identification of regulatory relationships in Parkinson's disease.

Authors:  Hao Wang; Cheng Sun; Yusi Liang; Heying Zhang; Yonggang Tan
Journal:  J Mol Neurosci       Date:  2013-02-21       Impact factor: 3.444

7.  The influence of NaIO(3)-induced retinal degeneration on intra-retinal layer and the changes of expression profile/morphology of DA-ACs and mRGCS.

Authors:  Zui Tao; Jiaman Dai; Jianrong He; Chunshi Li; Yaochen Li; Zheng Qin Yin
Journal:  Mol Neurobiol       Date:  2012-11-10       Impact factor: 5.590

Review 8.  MicroRNAs in Parkinson's disease.

Authors:  Maged M Harraz; Ted M Dawson; Valina L Dawson
Journal:  J Chem Neuroanat       Date:  2011-02-02       Impact factor: 3.052

Review 9.  MicroRNAs and neurodegeneration: role and impact.

Authors:  Masashi Abe; Nancy M Bonini
Journal:  Trends Cell Biol       Date:  2012-09-28       Impact factor: 20.808

10.  A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance.

Authors:  Monique Ohanian; David T Humphreys; Elizabeth Anderson; Thomas Preiss; Diane Fatkin
Journal:  BMC Genet       Date:  2013-03-06       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.